Skip to main navigation
Lion Biotechnologies
  • About
    • About Iovance Biotherapeutics
    • Management Team
    • Board of Directors
    • Research Partners
  • Our Technology
    • About TIL
    • Application of TIL
    • Publication and Scientific Presentations
  • Clinical
    • Clinical Program
    • Clinical Pipeline
    • Unmet Medical Need
    • Metastatic Melanoma
    • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    • Cervical Carcinoma
    • Non Small Cell Lung Cancer (NSCLC)
  • Investors
    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Ownership Summary
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Financial Reports
      • Quarterly Results
      • Earnings Estimates
    • Fundamentals
      • Snapshot
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Ratios
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Corporate Profile
      • Information Request
      • E-mail Alerts
      • IR Contacts
  • Careers
    • Why Iovance?
    • Current Job Openings
  • Patients
  • News
  • Contact

About Lion Biotech

Home Investors Node

Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

  • Read more about Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences

Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021

  • Read more about Iovance Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021

Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer

  • Read more about Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer

Iovance Biotherapeutics to Present at Upcoming Conferences in December

  • Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in December

Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

  • Read more about Iovance Biotherapeutics Presents Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates

  • Read more about Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2020 Financial Results and Corporate Updates

Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020

  • Read more about Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020

Iovance Biotherapeutics to Present at Upcoming Conferences in November

  • Read more about Iovance Biotherapeutics to Present at Upcoming Conferences in November

Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

  • Read more about Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

Iovance Biotherapeutics to Present at Upcoming October Conferences

  • Read more about Iovance Biotherapeutics to Present at Upcoming October Conferences

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
  • Investor Toolkit
  • Print Page
  • RSS
  • E-mail Alerts
  • Home
    • hidden
  • About
  • Our Technology
  • Clinical
  • Investors
  • Careers

© 2021 Iovance Biotherapeutics, Inc All Rights Reserved.

  • Privacy Policy
  • Disclaimer
  • Sitemap